BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32150626)

  • 1. Epidermal Growth Factor Receptor Expression of Colorectal Carcinoma in Nigerian Patients.
    Lawan AI; Ogunbiyi JO
    West Afr J Med; 2020; 37(2):100-105. PubMed ID: 32150626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of membranous epidermal growth factor receptor in colorectal adenocarcinoma and its correlation with clinicopathological features.
    Mohammadi G; Jamialahmadi K; Lary S; Ghaffarzadegan K
    Pak J Biol Sci; 2011 Mar; 14(5):357-62. PubMed ID: 21874828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Epidermal Growth Factor Receptor in Colorectal Adenocarcinoma and its Correlation with Clinicopathological Factors.
    Nemanqani DM; Aftab K; Al-Malki SH; Al-Sufyani WM
    J Coll Physicians Surg Pak; 2018 Jul; 28(7):527-531. PubMed ID: 29950257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of epidermal growth factor receptor (EGFR) in colorectal cancer: An immunohistochemical study.
    Ben Brahim E; Ayari I; Jouini R; Atafi S; Koubaa W; Elloumi H; Chadli A
    Arab J Gastroenterol; 2018 Sep; 19(3):121-124. PubMed ID: 30243897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic significance of EGFR and Her-2/neu in colorectal adenocarcinomas.
    Kountourakis P; Pavlakis K; Psyrri A; Rontogianni D; Xiros N; Patsouris E; Pectasides D; Economopoulos T
    Cancer J; 2006; 12(3):229-36. PubMed ID: 16803682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases.
    Goos JA; Hiemstra AC; Coupé VM; Diosdado B; Kooijman W; Delis-Van Diemen PM; Karga C; Beliën JA; Menke-van der Houven van Oordt CW; Geldof AA; Meijer GA; Hoekstra OS; Fijneman RJ; ;
    Br J Cancer; 2014 Aug; 111(4):749-55. PubMed ID: 24983372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGFR expression variance in paired colorectal cancer primary and metastatic tumors.
    Yarom N; Marginean C; Moyana T; Gorn-Hondermann I; Birnboim HC; Marginean H; Auer RC; Vickers M; Asmis TR; Maroun J; Jonker D
    Cancer Biol Ther; 2010 Sep; 10(5):416-21. PubMed ID: 20595818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discordance between EGFR expression and clinicopathologic parameters of colorectal adenocarcinoma in Taiwan.
    Tsai WC; Lin CK; Lee HS; Chen A; Nieh S; Yu CP; Wu CC; Jao SW; Jin JS
    Chin J Physiol; 2012 Oct; 55(5):352-60. PubMed ID: 23282210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological Value Of Epidermal Growth Factor Receptor (EGFR) And Ki-67 Expression In Colorectal Adenoma And Adenocarcinoma.
    Ahmed Nor EM; Saied EM; Mina SN; Shareef MM; Abdelaziz DM
    J Pak Med Assoc; 2023 Apr; 73(Suppl 4)(4):S124-S130. PubMed ID: 37482844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human epidermal growth factor receptor-2 family in colorectal adenocarcinoma: correlation with survival and clinicopathological findings.
    Molaei M; Pejhan S; Nayer BN; Moradi A; Ghiasi S; Zali MR
    Eur J Gastroenterol Hepatol; 2009 Mar; 21(3):289-93. PubMed ID: 19279475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the epidermal growth factor receptor (EGFR) in colorectal tumours and lymph node metastases.
    McKay JA; Murray LJ; Curran S; Ross VG; Clark C; Murray GI; Cassidy J; McLeod HL
    Eur J Cancer; 2002 Nov; 38(17):2258-64. PubMed ID: 12441262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of epidermal growth factor (EGF) and epidermal growth factor receptor (EGFR) in gastric and colorectal carcinomas. An immunohistological study of 63 cases.
    Karameris A; Kanavaros P; Aninos D; Gorgoulis V; Mikou G; Rokas T; Niotis M; Kalogeropoulos N
    Pathol Res Pract; 1993 Mar; 189(2):133-7. PubMed ID: 8321742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strong nuclear EGFR expression in colorectal carcinomas is associated with cyclin-D1 but not with gene EGFR amplification.
    Dekanić A; Dintinjan RD; Budisavljević I; Pećanić S; Butorac MŽ; Jonjić N
    Diagn Pathol; 2011 Nov; 6():108. PubMed ID: 22050898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Id-1: regulator of EGFR and VEGF and potential target for colorectal cancer therapy.
    Meteoglu I; Meydan N; Erkus M
    J Exp Clin Cancer Res; 2008 Nov; 27(1):69. PubMed ID: 19014499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple and reproducible scoring system for EGFR in colorectal cancer: application to prognosis and prediction of response to preoperative brachytherapy.
    Zlobec I; Vuong T; Hayashi S; Haegert D; Tornillo L; Terracciano L; Lugli A; Jass J
    Br J Cancer; 2007 Mar; 96(5):793-800. PubMed ID: 17311026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical expression of bcl-2 in UICC stage I and III colorectal carcinoma patients: correlation with c-erbB-2, p53, ki-67, CD44, laminin and collagen IV in evaluating prognostic significance.
    Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
    Pol J Pathol; 2006; 57(3):149-59. PubMed ID: 17219742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FAK, CD44v6, c-Met and EGFR in colorectal cancer parameters: tumour progression, metastasis, patient survival and receptor crosstalk.
    Garouniatis A; Zizi-Sermpetzoglou A; Rizos S; Kostakis A; Nikiteas N; Papavassiliou AG
    Int J Colorectal Dis; 2013 Jan; 28(1):9-18. PubMed ID: 22733437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of expression patterns of c-erbB-2, p53, p16INK4A, p27KIP1, cyclin D1 and epidermal growth factor receptor in oesophageal adenocarcinoma: a tissue microarray study.
    Langer R; Von Rahden BH; Nahrig J; Von Weyhern C; Reiter R; Feith M; Stein HJ; Siewert JR; Höfler H; Sarbia M
    J Clin Pathol; 2006 Jun; 59(6):631-4. PubMed ID: 16731604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical expression of EGFR in colorectal carcinoma correlates with high but not low level gene amplification, as demonstrated by CISH.
    Hemmings C; Broomfield A; Bean E; Whitehead M; Yip D
    Pathology; 2009; 41(4):356-60. PubMed ID: 19404848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of epidermal growth factor receptor in normal colorectal mucosa, adenoma, and carcinoma.
    Koretz K; Schlag P; Möller P
    Virchows Arch A Pathol Anat Histopathol; 1990; 416(4):343-9. PubMed ID: 2106751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.